DIN 02352583 — APO-RILUZOLE 50 MG
APO-RILUZOLE is a tablet of Riluzole marketed by APOTEX INC. The full Riluzole monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02352583
- Brand name
- APO-RILUZOLE
- Active ingredient
- Riluzole
- Strength
- 50 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Antiglutamate agent (glutamate release inhibitor) for amyotrophic lateral sclerosis
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Riluzole products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02390299 | MYLAN-RILUZOLE | 50 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02242763 | RILUTEK | 50 MG | TABLET | SANOFI-AVENTIS CANADA INC | MARKETED |